Whole-liver radiotherapy concurrent with chemotherapy as a palliative treatment for colorectal patients with massive and multiple liver metastases: A retrospective study

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1597-1602

  Yin, Hang ^a   Lu, Kai ^b   Qiao, Wen Bo ^a   Zhang, Hai Yang ^a   Sun, Di ^a   You, Qing Shan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b DAQING OILFIELD CO LTD   (China)

Author keywords

Colorectal cancer; Liver metastases; Palliative therapy; Whole liver irradiation

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; BILIRUBIN; FLUOROURACIL;

AGED; ARTICLE; ASCITES; BLOOD; COLORECTAL TUMOR; DRUG EFFECT; ECHOGRAPHY; FEMALE; HUMAN; JAUNDICE; LIVER; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAIN; PALLIATIVE THERAPY; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RETROSPECTIVE STUDY;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ASCITES; BILIRUBIN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; JAUNDICE; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PAIN; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 84897017754     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1597     Document Type: Article

References (36)

1. Ajlouni MI, Merrick HW, Skeel RT, Dobelbower RJ. (1990) Concomitant radiation therapy and constant infusion FUdR for unresectable hepatic metastases. Am J Clin Oncol, 13, 532-5.
2. Borgelt BB, Gelber R, Brady LW, Griffin T, Hendrickson FR. (1981)The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys, 7, 587-91.
3. Bydder S, Spry NA, Christie DR, et al (2003). A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol, 47, 284-8.
4. Ben-Josef E, Normolle D, Ensminger WD, et al (2005). Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol, 23, 8739-47.
5. Ben-Josef E, Lawrence TS (2005). Radiotherapy for unresectable hepatic malignancies. Semin Radiat Oncol, 15, 273-8.
6. Chung KY, Kemeny N (2005). Regional and systemic chemotherapy for primary hepatobiliary cancers and for colorectal cancer metastatic to the liver. Semin Radiat Oncol, 15, 284-98.
7. Cunningham SC, Choti MA, Bellavance EC, Pawlik TM (2007). Palliation of hepatic tumors. Surg Oncol, 16, 277-91.
8. Chong VH, Bakar S, Sia R, et al (2013). Colorectal cancer screening among government servants in Brunei Darussalam. Asian Pac J Cancer Prev, 14, 7657-61.
9. Chiu J, Tang V, Leung R, et al (2013). Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis. Asian Pac J Cancer Prev, 14, 6585-90.
10. Dimri K, Pandey AK, Trehan R, Rai B, Kumar A (2013). Conventional radiotherapy with concurrent weekly cisplatin in locally advanced head and neck cancers of squamous cell origin-a single institution experience. Asian Pac J Cancer Prev, 14, 6883-8.
11. Eccles CL, Bissonnette JP, Craig T, et al (2008). Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies. Int J Radiat Oncol Biol Phys, 72, 582-8.
12. Hoyer M, Swaminath A, Bydder S, et al (2012). Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys, 82, 1047-57.
13. Krishnan S, Lin EH, Gunn GB, et al (2006). Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol, 29, 562-7.
14. Leibel SA, Pajak TF, Massullo V, et al (1987). A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys, 13, 1057-64.
15. Lochan R, White SA, Manas DM (2007). Liver resection for colorectal liver metastasis. Surg Oncol, 16, 33-45.
16. Lee WS, Kim MJ, Yun SH, et al (2008). Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg, 393, 13-9.
17. Lausch A, Sinclair K, Lock M, et al (2013). Determination and comparison of radiotherapy dose responses for hepatocellular carcinoma and metastatic colorectal liver tumours. Br J Radiol, 86, 20130147.
18. Mohiuddin M, Chen E, Ahmad N (1996). Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol, 14, 722-8.
19. Mornex F, Girard N, Beziat C, et al (2006). Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys, 66, 1152-8.
20. Malik HZ, Gomez D, Wong V, et al (2007). Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol, 33, 1003-9.
21. Mendez RA, Hoyer M (2012). Radiation therapy for liver metastases. Curr Opin Support Palliat Care, 6, 97-102.
22. Nordlinger B, Rougier P (2002). Liver metastases from colorectal cancer: the turning point. J Clin Oncol, 20, 1442-5.
23. Pulitano C, Bodingbauer M, Aldrighetti L, et al (2011). Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol, 18, 1380-8.
24. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M (1993). Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys, 27, 117-23.
25. Robertson JM, Lawrence TS, Walker S (1995). The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int J Radiat Oncol Biol Phys, 32, 445-50.
26. Symon Z, Levi M, Ensminger WD, Smith DE, Lawrence TS (2001). Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model. Int J Radiat Oncol Biol Phys, 50, 473-8.
27. Schefter TE, Kavanagh BD (2011). Radiation therapy for liver metastases. Semin Radiat Oncol, 21, 264-70.
28. Thirion P, Wolmark N, Haddad E, Buyse M, Piedbois P (1999). Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer. Ann Oncol, 10, 1317-20.
29. Topkan E, Onal HC, Yavuz MN (2008). Managing liver metastases with conformal radiation therapy. J Support Oncol, 6, 9-13.
30. Timmerman RD, Bizekis CS, Pass HI, et al (2009). Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin, 59, 145-70.
31. Tree AC, Khoo VS, Eeles RA, et al (2013). Stereotactic body radiotherapy for oligometastases. Lancet Oncol, 14, 28-37.
32. van der Pool AE, Mendez RA, Wunderink W, et al (2010). Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg, 97, 377-82.
33. Wang X, Hershman DL, Abrams JA, et al (2007). Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer, 97, 1606-12.
34. Xiang L, Wang Y, Hu BQ, Wu JB, Xia YF (2013). Preliminary results of a phase i/ii study of simultaneous boost irradiation radiotherapy for locally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 14, 7569-76.
35. Yeo SG, Kim DY, Kim TH, et al (2010). Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction. Radiat Oncol, 5, 97.
36. Zeng ZC, Tang ZY, Fan J, et al (2004). A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J, 10, 307-16.